425 related articles for article (PubMed ID: 23482656)
1. Genome-wide association study of susceptibility loci for cervical cancer.
Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
[TBL] [Abstract][Full Text] [Related]
2. A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.
Chen D; Hammer J; Lindquist D; Idahl A; Gyllensten U
Cancer Med; 2014 Feb; 3(1):190-8. PubMed ID: 24403192
[TBL] [Abstract][Full Text] [Related]
3. A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer.
Chen D; Gyllensten U
Cancer Med; 2014 Apr; 3(2):445-52. PubMed ID: 24520070
[TBL] [Abstract][Full Text] [Related]
4. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
6. Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.
Chen D; Enroth S; Liu H; Sun Y; Wang H; Yu M; Deng L; Xu S; Gyllensten U
Oncotarget; 2016 Jul; 7(27):42216-42224. PubMed ID: 27285765
[TBL] [Abstract][Full Text] [Related]
7. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
8. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women.
Lin P; Koutsky LA; Critchlow CW; Apple RJ; Hawes SE; Hughes JP; Touré P; Dembele A; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1037-45. PubMed ID: 11588129
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
11. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
[TBL] [Abstract][Full Text] [Related]
12. Protective association of HLA-DRB1*13:02, HLA-DRB1*04:06, and HLA-DQB1*06:04 alleles with cervical cancer in a Korean population.
Shim H; Park B; Shin HJ; Joo J; Yoon KA; Kim YM; Hayashi T; Tokunaga K; Kong SY; Kim JY
Hum Immunol; 2019 Feb; 80(2):107-111. PubMed ID: 30352277
[TBL] [Abstract][Full Text] [Related]
13. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
14. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population.
Säilä H; Pitkäniemi J; Tuomilehto J; Savolainen A; Alakulppi N; Tuomilehto-Wolf E; Leirisalo-Repo M; Aho K
J Rheumatol; 2004 Nov; 31(11):2281-5. PubMed ID: 15517645
[TBL] [Abstract][Full Text] [Related]
15. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J
Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171
[TBL] [Abstract][Full Text] [Related]
16. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.
Hasan ME; Matin M; Haque ME; Aziz MA; Millat MS; Uddin MS; Moghal MMR; Islam MS
Cancer Med; 2021 Mar; 10(5):1829-1838. PubMed ID: 33586351
[TBL] [Abstract][Full Text] [Related]
18. HLA class II susceptibility to cervical cancer among Tunisian women.
Ben Othmane Y; Ghazouani E; Mezlini A; Lagha A; Raïs M; Kochkar R; Zidi S; Afrit M; Mota-Vieira L; Yacoubi Loueslati B
Bull Cancer; 2012 Sep; 99(9):81-6. PubMed ID: 22863772
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
